Photo from wikipedia
See Gratwicke and Foltynie (doi:10.1093/brain/awx333) for a scientific commentary on this article. Cognitive impairments in Parkinson’s disease show variable onset, severity and progression. Ray et al. demonstrate that the future… Click to show full abstract
See Gratwicke and Foltynie (doi:10.1093/brain/awx333) for a scientific commentary on this article. Cognitive impairments in Parkinson’s disease show variable onset, severity and progression. Ray et al. demonstrate that the future cognitive status of newly diagnosed patients can be predicted from the volume of the nucleus basalis of Meynert, with implications for the development of interventions for cognitive decline in Parkinson’s disease dementia.
Keywords:
disease;
vivo cholinergic;
parkinson disease;
cognitive decline;
cholinergic basal
Journal Title: Brain
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Brain
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!